What you need to know The prevalence of heart failure across Europe is estimated to be 1-2% of adults.1 In the UK, this places a substantial burden on patients and healthcare resources, including ...

The problem starts with how doctors typically test for heart disease. Traditional lipid panels focus on cholesterol—a waxy substance that can build up in arteries—and triglycerides, a type of fat that ...

Background Pharmacotherapy combinations have been shown to improve survival and reduce hospitalisations in adults with ...

Beta blockers have been shown to prolong survival in chronic heart failure. It is currently a matter of debate whether any β blocker is superior to the other in terms of improving symptoms, left ...

A new report suggests that millions of U.S. adults are unaware they may have undiagnosed cardiovascular risk factors that ...

Some people with heart failure need to take multiple medicines each day to keep their symptoms under control. Heart failure is a chronic, or long-term, condition. It can lead to issues not only in the ...

Thousands of patients in England with early-stage chronic heart failure could benefit from earlier access to effective drug therapies under new draft guidance from the National Institute for Health ...

Please provide your email address to receive an email when new articles are posted on . Fluid restriction has long been recommended for patients with HF. Restricted vs. liberal fluid restriction did ...

A North Texas cardiologist says some of the increase stems from a direct physical impact by the virus on the heart. But much of it resulted from lack of access to health care.

New medical findings suggest that people who stay up late regularly could face a significantly higher risk of serious cardiovascular problems.